M.641 Ezetimibe co-administered with sim vastatin reduces C-reactive protein in a large cohort of hypercholesterolemic patients

2004 ◽  
Vol 5 (1) ◽  
pp. 148
Author(s):  
P SAGER
Keyword(s):  
Large Cohort ◽  
C Reactive Protein ◽  
Reactive Protein

scholarly journals Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients

2013 ◽  
Vol 110 (1) ◽  
pp. 183-188 ◽  
Author(s):  
J Szkandera ◽  
M Stotz ◽  
G Absenger ◽  
T Stojakovic ◽  
H Samonigg ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Patients ◽  
Prognostic Indicator ◽  
Large Cohort ◽  
C Reactive Protein ◽  
Protein Levels ◽  
Reactive Protein

Hyperuricaemia is associated with increased C-reactive protein concentrations in a large cohort of unselected outpatients

2008 ◽  
Vol 18 (8) ◽  
pp. e41-e42 ◽  
Author(s):  
Giuseppe Lippi ◽  
Giovanni Targher ◽  
Martina Montagnana ◽  
Gian Luca Salvagno ◽  
Gian Cesare Guidi
Keyword(s):  
Large Cohort ◽  
C Reactive Protein ◽  
Reactive Protein

M.641 Ezetimibe co-administered with sim vastatin reduces C-reactive protein in a large cohort of hypercholesterolemic patients

2004 ◽  
Vol 5 (1) ◽  
pp. 148
Author(s):  
P. Sager ◽  
R. Capece ◽  
L. Lipka ◽  
J. Strony ◽  
B. Yang ◽  
...  
Keyword(s):  
Large Cohort ◽  
C Reactive Protein ◽  
Reactive Protein

Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients

2005 ◽  
Vol 179 (2) ◽  
pp. 361-367 ◽  
Author(s):  
Philip T. Sager ◽  
Rachel Capece ◽  
Leslie Lipka ◽  
John Strony ◽  
Bo Yang ◽  
...  
Keyword(s):  
Large Cohort ◽  
C Reactive Protein ◽  
Reactive Protein
Sign in / Sign up

Export Citation Format

Share Document